170 related articles for article (PubMed ID: 10960274)
1. Mesalamine and relapse prevention in Crohn's disease.
Cottone M; Cammà C
Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
[No Abstract] [Full Text] [Related]
2. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
Bauer WM; Brzezinski A; Lashner BA
Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
[TBL] [Abstract][Full Text] [Related]
3. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
Prantera C; Bellinvia S
Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
[No Abstract] [Full Text] [Related]
4. 5-aminosalicylates to prevent relapse of Crohn's disease after surgery.
Doherty G; Moss AC
Am J Gastroenterol; 2012 Mar; 107(3):487; author reply 487-8. PubMed ID: 22388032
[No Abstract] [Full Text] [Related]
5. Mesalamine in the treatment of active Crohn's disease.
Dignass A; Marteau P
Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152
[No Abstract] [Full Text] [Related]
6. Mesalamine maintenance therapy for Crohn's disease.
Feagan BG; McDonald JW
Gastroenterology; 2001 Feb; 120(2):585-6. PubMed ID: 11271451
[No Abstract] [Full Text] [Related]
7. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.
Cottone M; Orlando A; Viscido A; Calabrese E; Cammà C; Casà A
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():38-42. PubMed ID: 12786611
[TBL] [Abstract][Full Text] [Related]
8. Mesalamine derivatives in the treatment of Crohn's disease.
Harrell LE; Hanauer SB
Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
[TBL] [Abstract][Full Text] [Related]
9. Mesalazine as a maintenance treatment in Crohn's disease.
Sutherland LR; Steinhart AH
Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902
[No Abstract] [Full Text] [Related]
10. Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.
Akobeng AK
Am J Gastroenterol; 2011 Oct; 106(10):1857; author reply 1857-8. PubMed ID: 21979212
[No Abstract] [Full Text] [Related]
11. Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.
Kamm MA
Inflamm Bowel Dis; 2005 Jun; 11(6):616-7. PubMed ID: 15905712
[TBL] [Abstract][Full Text] [Related]
12. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Hayee BH; Harris AW
Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
[No Abstract] [Full Text] [Related]
13. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
14. [Improved treatment of Crohn's disease].
Nau JY
Rev Med Suisse; 2005 May; 1(18):1241. PubMed ID: 15977716
[No Abstract] [Full Text] [Related]
15. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
Rutgeerts P
Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
[No Abstract] [Full Text] [Related]
16. A comparison of budesonide and mesalamine for active Crohn's disease.
Lowry PW; Sandborn WJ
Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
[No Abstract] [Full Text] [Related]
17. The case against using 5-aminosalicyclates in Crohn's disease: con.
Stange EF
Inflamm Bowel Dis; 2005 Jun; 11(6):613-5. PubMed ID: 15905711
[No Abstract] [Full Text] [Related]
18. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables.
Cammà C; Giunta M; Rosselli M; Cottone M
Gastroenterology; 1997 Nov; 113(5):1465-73. PubMed ID: 9352848
[TBL] [Abstract][Full Text] [Related]
19. Mesalamine for the prevention of postoperative recurrence: is nearly there the same as being there?
Sutherland LR
Gastroenterology; 2000 Feb; 118(2):436-8. PubMed ID: 10648473
[No Abstract] [Full Text] [Related]
20. The case for using 5-aminosalicyclates in Crohn's disease: pro.
Hanauer SB
Inflamm Bowel Dis; 2005 Jun; 11(6):609-12. PubMed ID: 15905710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
